OROKEN for children 100 mg/5 ml, powder for oral suspension in a vial bottle, 13.33 g
Active ingredients: Anhydrous cefixime, Cefixime trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral suspensionbottle, 13.33 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OROKEN ENFANTS 100 mg/5 ml, poudre pour suspension buvable en flacon
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 13,33 g avec mesurette(s) graduée(s) polyéthylène de 5 ml
- Marketing authorisation holder
- AMDIPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Feb 1994
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66907450CIP73358989CIP133400933589899Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFIXIME TRIHYDRATÉEpoudre | — | SA |
| CÉFIXIME ANHYDREpoudre | 0,80 g · 13,3 g | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.